Connor, Clark & Lunn Investment Management (CC&L)’s Fortress Biotech FBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-4,299
| Closed | -$42.2K | – | 1311 |
|
2022
Q4 | $42.2K | Sell |
4,299
-421
| -9% | -$4.14K | ﹤0.01% | 1154 |
|
2022
Q3 | $61K | Buy |
4,720
+977
| +26% | +$12.6K | ﹤0.01% | 1061 |
|
2022
Q2 | $47K | Buy |
3,743
+2,227
| +147% | +$28K | ﹤0.01% | 1007 |
|
2022
Q1 | $31K | Buy |
1,516
+279
| +23% | +$5.71K | ﹤0.01% | 1008 |
|
2021
Q4 | $46K | Sell |
1,237
-657
| -35% | -$24.4K | ﹤0.01% | 1048 |
|
2021
Q3 | $91K | Buy |
+1,894
| New | +$91K | ﹤0.01% | 986 |
|
2020
Q2 | – | Sell |
-1,107
| Closed | -$31K | – | 1068 |
|
2020
Q1 | $31K | Buy |
+1,107
| New | +$31K | ﹤0.01% | 979 |
|
2015
Q4 | – | Sell |
-860
| Closed | -$34K | – | 827 |
|
2015
Q3 | $34K | Sell |
860
-1,313
| -60% | -$51.9K | ﹤0.01% | 698 |
|
2015
Q2 | $110K | Buy |
+2,173
| New | +$110K | ﹤0.01% | 588 |
|